Merck & Co., Inc. (MRK) Stock Grade

About Merck & Co., Inc.'s fundamentals

Merck is a large-cap pharmaceutical manufacturer with a market capitalization of $263.4 billion and a notably high net profit margin of 28.1%, indicating strong cost control and profitability relative to revenue. The company generated a 34.7% return on equity, demonstrating efficient use of shareholder capital, while trading at a P/E ratio of 14.4—below the typical range for large pharmaceutical companies. Revenue grew modestly at 1.2% year-over-year, reflecting the slower expansion common in mature pharmaceutical markets, though the company returns capital to shareholders through a 3.1% dividend yield.